Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Simultaneous Engagement of Networks for Alleviating Pain (SENAP)

NCT: NCT07057206 · NOT_YET_RECRUITING

NCT IDNCT07057206
StatusNOT_YET_RECRUITING
Start Date2026-11-01
Completion2030-12
SponsorUniversity of Minnesota (OTHER)
First posted
Last updated

Brief Summary

This trial is investigating the acceptability and efficacy of PFM-guided cortical stimulation for the treatment of central neuropathic pain.

Frequently Asked Questions

What is Simultaneous Engagement of Networks for Alleviating Pain (SENAP)?

Simultaneous Engagement of Networks for Alleviating Pain (SENAP) is a clinical trial registered under NCT07057206. Current status: NOT_YET_RECRUITING.

What is the status of NCT07057206?

The current status of NCT07057206 (Simultaneous Engagement of Networks for Alleviating Pain (SENAP)) is: NOT_YET_RECRUITING.

When did Simultaneous Engagement of Networks for Alleviating Pain (SENAP) start?

Simultaneous Engagement of Networks for Alleviating Pain (SENAP) started on 2026-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑